Loidreau Yvonnick, Dubouilh-Benard Carole, Nourrisson Marie-Renée, Loaëc Nadège, Meijer Laurent, Besson Thierry, Marchand Pascal
Normandie Université, UNIROUEN, INSA Rouen, CNRS, COBRA UMR 6014, F-76000 Rouen, France.
Université de Nantes, Cibles et Médicaments des Infections et du Cancer, IICiMed, EA 1155, F-44000 Nantes, France.
Pharmaceuticals (Basel). 2020 May 9;13(5):89. doi: 10.3390/ph13050089.
We previously highlighted the interest in 6,5,6-fused tricyclic analogues of 4-aminoquinazolines as kinase inhibitors in the micromolar to the nanomolar range of IC values. For the generation of chemical libraries, the formamide-mediated cyclization of the cyanoamidine precursors was carried out under microwave irradiation in an eco-friendly approach. In order to explore more in-depth the pharmacological interest in such tricyclic skeletons, the central five member ring, i.e., thiophène or furan, was replaced by a pyrrole to afford 9H-pyrimido[5,4-b]- and [4,5-b]indol-4-amine derivatives inspired from harmine. The inhibitory potency of the final products was determined against four protein kinases (CDK5/p25, CK1/ε, GSK3 and DYRK1A). As a result, we have identified promising compounds targeting CK1/ε and DYRK1A and displaying micromolar and submicromolar IC values.
我们之前强调了对4-氨基喹唑啉的6,5,6-稠合三环类似物作为激酶抑制剂的兴趣,其IC值在微摩尔至纳摩尔范围内。为了生成化学文库,氰基脒前体的甲酰胺介导的环化反应在微波辐射下以环保的方式进行。为了更深入地探索对此类三环骨架的药理学兴趣,将中心五元环(即噻吩或呋喃)替换为吡咯,以得到受哈尔明启发的9H-嘧啶并[5,4-b]-和[4,5-b]吲哚-4-胺衍生物。测定了最终产物对四种蛋白激酶(CDK5/p25、CK1δ/ε、GSK3α/β和DYRK1A)的抑制效力。结果,我们鉴定出了靶向CK1δ/ε和DYRK1A且IC值为微摩尔和亚微摩尔的有前景的化合物。